
Lorpucitinib
CAS No. 2230282-02-5
Lorpucitinib( —— )
Catalog No. M35614 CAS No. 2230282-02-5
Lorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 347 | In Stock |
![]() ![]() |
5MG | 543 | In Stock |
![]() ![]() |
10MG | 867 | In Stock |
![]() ![]() |
25MG | 1592 | In Stock |
![]() ![]() |
50MG | 2567 | In Stock |
![]() ![]() |
100MG | 3393 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameLorpucitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLorpucitinib (JNJ-64251330) is an orally available, selective and potent JAK kinase inhibitor for the study of inflammatory and gastrointestinal disorders associated with Janus kinase (JAK) signaling.
-
DescriptionLorpucitinib is a Gut-Restricted JAK Inhibitor for the research of Inflammatory Bowel Disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2230282-02-5
-
Formula Weight408.5
-
Molecular FormulaC22H28N6O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (612.00 mM; Ultrasonic )
-
SMILESCC(C)(O)CNC(=O)Cc1nc2cnc3[nH]ccc3c2n1[C@H]1CC[C@H](CC#N)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leonard KA, Madge LA, Krawczuk PJ, Wang A, Kreutter KD, Bacani GM, Chai W, Smith RC, Tichenor MS, Harris MC, Malaviya R, Seierstad M, Johnson ME, Venable JD, Kim S, Hirst GC, Mathur AS, Rao TS, Edwards JP, Rizzolio MC, Koudriakova T. Discovery of a Gut-Re?
molnova catalog



related products
-
JAK3-IN-2
A potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM.
-
Fosifidancitinib
Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.
-
PF-06700841
PF-06700841 is a potent, selective TYK2/JAK1 kinase inhibitor that reduces IL-23 expression and directly attenuates IL-23 signaling via TYK2.